At a glance
One platform. Powering endless possibilities.
MyBreastAI Suite offers a comprehensive collection of proven AI apps - from our partner iCAD - assisting you to personalize breast cancer screening.
Revolutionizing breast cancer screening
INCREASE SENSITIVITY
ProFound AI® for DBT
STANDARDIZED REPORTINGS
PowerLook® Density Assessment
BREAST CANCER DETECTION
ProfoundAI for 2D
REFERENCES
2. With a service contract.
3. iCAD data on file. FDA filing: K203822. Standalone performance varies by vendor. FDA Cleared and CE Mark Pending. Reading times may vary based on the specific functionality of the viewing application used for interpretation.
4. Reader performance with Profound AI compared to performance without.
iCAD reader study: Conant, E et al. (2019). Improving Accuracy and Efficiency with Concurrent Use of Artificial Intelligence for Digital Breast Tomosynthesis. Radiology: Artificial Intelligence. 1 (4). Accessed via https://pubs.rsna.org/doi/10.1148/ryai.2019180096
iCAD labelling and user manual, DTM160 rev C.
5. Sprague B, Conant E, Onega T et al. Variation in Mammographic Breast Density Assessments Among Radiologists in Clinical Practice: A Multicenter Observational Study. Ann Intern Med. 2016; 165(7):457-464. doi:10.7326/M15-2934.
6. iCAD labelling and user manual, DTM135-1, DTM156 -3, DTM184 rev1.
7. iCAD labelling and user manual, DTM103 - Revision C.